The emerging therapy of the medication represents a exciting development in the management of type 2 diabetes. Unlike existing medications, tirzepatide targets two pathways – GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) – providing improved blood sugar control and anticipated weig